Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028
상품코드:1558512
리서치사:TechNavio
발행일:2024년 08월
페이지 정보:영문 123 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
NTRK 융합 유전자 양성 진행성 고형암 시장은 2023-2028년간 9,260만 달러 확대되고, 예측 기간 동안 4.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서는 NTRK 융합 유전자 양성 진행성 고형암 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 암 발병률 증가, 암 조기 발견에 대한 관심 증가, 분자진단에 대한 수요 증가로 인해 시장이 주도되고 있습니다.
시장 범위
기준년도
2024년
종료년도
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
2024년 전년 대비
4.23%
CAGR
4.5%
증분 금액
9,260만 달러
이 보고서는 향후 몇 년동안 NTRK 융합 유전자 양성 진행성 고형암 시장의 성장을 가속하는 주요 이유 중 하나로 바이오마커 기반 검사에 대한 높은 수요를 꼽았습니다. 또한, 연구 개발 증가, 기술 발전, 새로운 치료 전략이 시장의 큰 수요를 창출할 것으로 예상됩니다.
The NTRK fusion gene positive advanced solid tumor market is forecasted to grow by USD 92.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the NTRK fusion gene positive advanced solid tumor market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, increasing focus on the early detection of cancer, and growing demand for molecular diagnostics.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
4.23%
CAGR
4.5%
Incremental Value
$92.6 mn
Technavio's NTRK fusion gene positive advanced solid tumor market is segmented as below:
By Application
Clinical
Research
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the high demand for biomarker-based tests as one of the prime reasons driving the NTRK fusion gene positive advanced solid tumor market growth during the next few years. Also, increase in research and development and advances in technology and emerging treatment strategies will lead to sizable demand in the market.
The report on the NTRK fusion gene positive advanced solid tumor market covers the following areas:
NTRK fusion gene positive advanced solid tumor market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NTRK fusion gene positive advanced solid tumor market vendors that include Bayer AG, Empire Genomics Inc., F. Hoffmann La Roche Ltd., LGC Clinical Diagnostics Inc., NeoGenomics Laboratories Inc., and OncoDNA. Also, the NTRK fusion gene positive advanced solid tumor market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
